Evaluating the Response and Safety of Inactivated COVID-19 Vaccines in Liver Transplant Recipients

PURPOSE: To evaluate the response and safety of an inactivated vaccine (Sinovac Life Sciences Co., Ltd., Beijing, China) for coronavirus disease 2019 (COVID-19) in liver transplant (LTx) recipients from China. PATIENTS AND METHODS: Thirty-five recipients post LTx from the First Affiliated Hospital o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Zhen-Hua, Jin, Ping-Bo, Chen, Di-Yu, Chen, Zhi-Yun, Li, Zhi-Wei, Wu, Jie, Lou, Bin, Zhang, Bao-Shan, Zhang, Lin, Zhang, Wei, Liang, Ting-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112169/
https://www.ncbi.nlm.nih.gov/pubmed/35592105
http://dx.doi.org/10.2147/IDR.S359919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112169/
https://www.ncbi.nlm.nih.gov/pubmed/35592105
http://dx.doi.org/10.2147/IDR.S359919

Ejemplares similares